Home Insights and News
Show
blank_164_164
24 February 2022
Notes from the Trenches: Lessons Learned in Engineering Novel Drug Facilities
Read Labcompare's "Notes from the Trenches: Lessons Learned in Engineering Novel Drug Therapy Facilities," article written by DPS Group's Jeff Lewis, Ryan McDonough, and Eddie Skillington.
blank_164_164
21 February 2022
Lean Construction Ireland Annual Book of Cases 2021, Case 5
Read how DPS implements lean thinking and practices in Case 5 of the LCi Book of Cases 2021, which was co-authored by the following DPS Group team: Dara Quirke, Sean Kinnane, David McCarthy and William Power.
blank_164_164
15 February 2022
DPS Group Opens Office in Kansas City and Names Mark Potts Senior Vice President of Operations
As part of our continued growth, DPS is excited to open our new office in Kansas City, offering specialized architectural, engineering, construction management, and commissioning, qualification, and validation (CQV) services.
blank_164_164
11 February 2022
The Semiconductor Construction Conundrum
In 2021, the cracks in the Semiconductor Global supply chain were exposed, and several industries and economies’ dependency on the supply of semiconductors came to the fore.
blank_164_164
27 January 2022
Oligonucleotide Synthesis – Overcoming Production Scale Limitations
The demand for oligonucleotide facilities has increased significantly in the past year and is likely to continue. Read Joseph Laviano's article “Oligonucleotide Synthesis – Overcoming Production Scale Limitations” for engineering solutions in this space.
blank_164_164
16 December 2021
Four Trends to Watch in Pharma Facility Design for 2022
Where is the pharma manufacturing industry headed in 2022 and beyond? In understanding the implications of supply chain issues and delays in manufacturing outsourcing, it’s clear that we’re are at the cusp of change when it comes to facility design.